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Developing Schwann Cells Acquire the Ability to Survive without
Axons by Establishing an Autocrine Circuit Involving Insulin-Like
Growth Factor, Neurotrophin-3, and Platelet-Derived
Growth Factor-BB
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Although Schwann cell precursors from early embryonic nerves
die in the absence of axonal signals, Schwann cells in older
nerves can survive in the absence of axons in the distal stump
of transected nerves. This is crucially important, because suc-
cessful axonal regrowth in a damaged nerve depends on inter-
actions with living Schwann cells in the denervated distal
stump. Here we show that Schwann cells acquire the ability to
survive without axons by establishing an autocrine survival
loop. This mechanism is absent in precursors. We show that
insulin-like growth factor, neurotrophin-3, and platelet-derived
growth factor-BB are important components of this autocrine
survival signal. The secretion of these factors by Schwann cells
has signiﬁcant implications for cellular communication in de-
veloping nerves, in view of their known ability to regulate sur-
vival and differentiation of other cells including neurons.
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Survival regulation by signals that block or activate programmed
cell death is important for the development and function of many
systems, including the nervous system (Wyllie, 1980; Ellis and
Youson, 1990; Oppenheim et al., 1991; Raff et al., 1993). We
raised the issue of survival regulation during Schwann cell devel-
opment by showing that Schwann cells from embryonic day 18
(E18) or newborn nerves survived for 24 hr when plated without
neurons at moderate cell density, although Schwann cell precur-
sors from E14 nerves died by apoptosis under identical conditions
(Jessen et al., 1994; Dong et al., 1995). We found that
b-neuregulin-1 acted as a survival factor in this lineage, because
b-neuregulin-1 prevented apoptosis of precursors and sustained
their survival for several days, during which they converted to
Schwann cells (Dong et al., 1995). These and related in vivo
studies (Riethmacher et al., 1997) have now established that
Schwann cell precursors depend on axons for survival, and that a
major component of the axonal survival signal is b-neuregulin-1,
which binds to ErbB3 receptors on the precursor cells (Jessen and
Mirsky, 1997; for review, see Mirsky and Jessen, 1998).
More recently, it has become clear that Schwann cells also
undergo programmed cell death. Apoptotic Schwann cells are
present in nerves from newborn rats, and transection of neonatal
nerves increases the amount of apoptosis, although this is not
seen if 20-d-old nerves are cut (Grinspan et al., 1996; Syroid et al.,
1996; Trachtenberg and Thompson, 1996). Even in neonatal
nerves it is clear that most Schwann cells survive nerve transec-
tion and the ensuing loss of axonal contact, and in adult nerves no
signiﬁcant Schwann cell death follows denervation (Trachtenberg
and Thompson, 1996).
This raises the question of how Schwann cells survive in the
absence of axons. This issue is critical in the context of nerve
regeneration. In the nerve segment distal to an injury, Schwann
cells are left without axons. For successful repair, the axons have
to grow back through this segment to reach their targets. This
axon regrowth is heavily dependent on the presence of living
Schwann cells in the distal stump, presumably because the axons
require interactions with Schwann cell-associated adhesion mol-
ecules and trophic factors (Hall, 1986; Fawcett and Keynes, 1990;
Nadim et al., 1990). Nerve regeneration, therefore, depends on
the mechanism that allows Schwann cells, unlike their precursors,
to survive in the absence of axons.
We have now investigated the possibility that this is achieved by
an autocrine loop, i.e., that Schwann cells might sustain their own
survival by secretion of factors that block Schwann cell apoptosis.
Using cell cultures we demonstrate the existence of autocrine
survival loops in Schwann cells from E18 and postnatal nerves
and ﬁnd that these loops are absent from Schwann cell precursors.
We provide evidence that the autocrine survival activity resides
in a mixture of growth factors, including insulin-like growth
factors (IGFs), platelet derived growth factor-BB (PDGF-BB),
and neurotrophin-3 (NT-3), that acts synergistically to block
Schwann cell death, although it does not prevent the death of
Schwann cell precursors.
MATERIALS AND METHODS
All neutralizing monoclonal antibodies were used in the form of cell
culture supernatant. A neutralizing monoclonal NT-3 antibody (mAb 12)
was a gift from Dr. Y.-A. Barde (MPI, Martinsried, Germany) and Dr. I.
Bartke (Boehringer Mannheim, Mannheim, Germany) (Gaese et al.,
1994), and another polyclonal NT-3-neutralizing antibody, G1651, was
obtained from Promega (Southampton, UK). The supernatant of the
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The Journal of Neuroscience, May 15, 1999, 19(10):3847–3859SM1.2 hybridoma cell line containing IGF-neutralizing antibodies, de-
veloped by Drs. J. J. Van Wyk and L. E. Underwood, was obtained from
the Developmental Studies Hybridoma Bank maintained by the Univer-
sity of Iowa (Iowa City, IA) under contract NO-I-HD-7-3263 from the
National Institute of Child Health and Human Development. This anti-
body binds both IGF-1 and -2. Neutralizing polyclonal IGF-2 antibody
AF-292 was obtained fromR&DSystems (Oxon, UK). The AF-292
antibody does not neutralize IGF-1 according to the manufacturer’s
instructions. Blocking anti-IGF receptor I monoclonal antibodies
(GR11L) were from Calbiochem-Novabiochem (Nottingham, UK). Neu-
tralizing polyclonal PDGF-BB antibodies were from New Brunswick
Scientiﬁc (Huntingdon, UK). Monoclonal DG2 antibodies neutralizing
ﬁbroblast growth factor-2 (FGF-2) were a gift from Dr. T. M. Reilly
(DuPont Merck Pharmaceutical, Wilmington, DE) (Reilly et al., 1989).
Neutralizing DB1 mouse anti-rat antibodies against interferon-g
(IFN-g) were a gift from P. H. Van der Meide. Polyclonal anti-brain-
derived neurotrophic factor (BDNF) neutralizing antibodies were ob-
tained from Promega (Southampton, UK), and panspeciﬁc transforming
growth factor b (TGF-b) neutralizing antibodies were fromR&D
Systems.
IGF-1 and IGF-2 proteins were a gift from Kabi Pharmacia (Milton
Keynes, UK). PDGF-BB and FGF-2 proteins were obtained from Pep-
rotech (London, UK). NT-3, NT-4, and BDNF recombinant proteins
were a gift from Regeneron Pharmaceuticals (Tarrytown, NY). Neu-
regulins were a gift from Dr. B. Ratzkin, (Amgen, Thousand Oaks, CA).
Sensory and motor neuron-derived factor was a gift from Genentech (San
Francisco, CA). Recombinant TGF-b isoforms and leukemia-inhibitory
factor (LIF) protein were obtained fromR&DSystems; endothelins 1
and 3 were from Cambridge Research Chemicals (Cheshire, UK). Re-
combinant glial-derived neurotrophic factor was obtained from Alomone
Labs (Jerusalem, Israel), and nerve growth factor 2.5S was from Promega
(Southampton, UK). Tissue culture plastics were obtained from Falcon
(Becton Dickinson, Cowley, UK) and Corning Costar (High Wycombe,
UK), and culture media were from Life Technologies (Paisley, UK).
Hyaluronidase, trypsin inhibitor, leupeptin, dimethylsulfoxide (DMSO),
and tissue culture substrates were from Sigma (Poole, UK); collagenase
was from Worthington (Lorne Laboratories, Reading, UK). Terminal
transferase enzyme and buffer as well as biotin-16-dUTP nucleotides
were obtained from Boehringer Mannheim (Lewes, UK); the ﬂuores-
ceinated avidin conjugate was from Vector Laboratories (Burlingame,
CA). RT-PCR reagents were obtained from Promega. Reverse transcrip-
tase and primer pairs were from Life Technologies. Ultraspec RNA total
RNA isolation reagent was from Biotecx Laboratories (Houston, TX).
Sources of other materials used in cell culture, immunocytochemistry,
and RT-PCR have been detailed in previous papers (Jessen et al., 1994;
Morgan et al., 1994; Dong et al., 1995; Blanchard et al., 1996).
Preparation of Schwann cell precursor and Schwann cell cultures.
Throughout this study, Sprague Dawley rats were used. Cultures of
Schwann cell precursors and Schwann cells from E18, newborn, and
7-d-old rats were prepared essentially as described previously (Jessen et
al., 1990, 1994). After dissociation, Schwann cell precursors or embryonic
Schwann cells were resuspended in deﬁned medium without serum,
counted, and plated at varying densities in a 20 ml drop onto poly-L-
ornithine (PORN)-coated or poly-L-lysine- and laminin-coated cover-
slips. After 3 hr, the cultures were topped up with 380 ml of different
experimental media. The whole procedure was serum-free. Immunopan-
ning was used to purify newborn Schwann cells (see below) before plating
onto coverslips.
Puriﬁcation of newborn Schwann cells by immunopanning. Negative
immunopanning of Schwann cells was performed as described previously
(Dong et al., 1997; Lee et al., 1997). Schwann cells are 99.5 6 0.4% pure
after immunopanning as assessed by S100 staining (see below). For the
preparation of Schwann cell conditioned medium, 2.5 3 10
6 cells were
plated onto a 35-mm-diameter poly-L-lysine- and laminin-coated dish in
1.2 ml of deﬁned medium. To prevent protein degradation, cells were
cultured in the presence of 20 mM leupeptin. After a culture period of 24
hr the supernatant (conditioned medium) was collected, centrifuged for
10 min at 1000 rpm, and stored in BSA-coated cryotubes at 270°C or
used immediately. Before use, the conditioned medium was diluted in
leupeptin-containing culture medium.
Deﬁned medium. In most Schwann cell experiments a simple medium
consisting of 1:1 DMEM and Ham’s F-12 supplemented with bovine
serum albumin (350 mg/ml) was used (referred to as simple deﬁned
medium or deﬁned medium). In most precursor and some Schwann cell
experiments we used a supplemented deﬁned medium, identical to that
used in previous studies (referred to as supplemented deﬁned medium;
Jessen et al., 1994). It consists of a 1:1 mixture of DMEM and Ham’s
F-12 supplemented with (ﬁnal concentration in parentheses) transferrin
(100 mg/ml), progesterone (60 ng/ml), putrescine (16 mg/ml), insulin (5
mg/ml), thyroxine (0.4 mg/ml), selenium (160 ng/ml), triiodothyronine
(10.1 ng/ml), dexamethasone (38 ng/ml), glucose (7.9 mg/ml), bovine
serum albumin (0.3 mg/ml), penicillin (100 IU/ml), streptomycin (100
IU/ml), and glutamine (2 mM).
Survival assay. The survival assay used in these experiments is a
modiﬁcation of that used previously for Schwann cell precursors (Jessen
et al., 1994; Dong et al., 1995). Brieﬂy, at 3 hr and at speciﬁed times after
plating, cells were ﬁxed with 2% paraformaldehyde in PBS for 20 min.
After washing, cells were mounted in Citiﬂuor mounting medium con-
taining 4 mg/ml Hoechst dye. The number of living cells in this assay is
expressed either as survival percent or rescue percent. Survival percent
is the number of living cells present at the end of the experiment
expressed as a percentage of the number of cells that had plated suc-
cessfully at the beginning of the experiment, i.e., the number of cells that
had attached and begun to ﬂatten on the substrate 3 hr after plating.
Rescue percent is obtained by subtracting the number of cells in control
sister cultures (i.e., the cells that survive without added survival factors)
from the number of cells in a test culture (i.e., in the presence of added
factors). This represents the number of cells rescued by the added
factors. It is expressed as a percentage of the theoretical maximum
rescue, which is the difference between the number of cells in control
cultures (without added factors) and the number of cells that plated
successfully at the beginning of the experiment (see above). Routinely,
dead cells were identiﬁed by observing Hoechst nuclear staining and
obvious morphological changes associated with death. Thus cells classi-
ﬁed as dead showed either clearly elevated intensity of Hoechst nuclear
labeling or nuclei that had fragmented, showing two or more Hoechst-
labeled bodies per cell, and had in addition retracted processes and
cytoplasm that by phase contrast appeared granulated and most often
also vacuolated; the nucleus of these cells appeared condensed and/or
fragmented by phase contrast. To validate the classiﬁcation of these cells
as dead, we examined cultures of dying cells that had been labeled with
the terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick
end-labeling (TUNEL) method and classiﬁed the cells using these crite-
ria. It was found that 98% of the cells that were recorded as dead using
the above criteria were also TUNEL-positive. We used 13 mm cover-
slips, and in every case the total number of cells on the whole coverslip
was counted.
Antibody blocking experiments and immunohistochemistry. Antibody
concentrations for the neutralization of conditioned medium were deter-
mined for every antibody individually; neutralizing concentrations for
the SM1.2 (IGF) and DG2 (FGF-2) antibodies were determined in
Schwann cell proliferation assays (Stewart et al., 1991). Treatment with
FGF-2, IGF-1, and forskolin resulted in .80% bromodeoxyuridine
(BrdU)-positive cells, which was reduced to control levels in the presence
of 2.64 mg/ml SM1.2 or 1 mg/ml DG2 antibodies, respectively. Anti-
PDGF-BB antibodies were also tested in a BrdU incorporation assay;
concentrations of 12 mg/ml fully blocked BrdU incorporation in PDGF-
BB, IGF, and forskolin. For the IGF-2 antibody, the optimal concentra-
tion was determined by the reduction in survival rates of neonatal
Schwann cells in 10 ng/ml IGF-2, which was reduced to control levels at
concentrations of 5 mg/ml anti-IGF antibody AF-292. Neutralization
with the anti-NT-3 antibody mAb 12 has been described previously
(Gaese et al., 1994); the concentration used was 50 mg/ml. Concentra-
tions for the NT-3 antibody G1651 were determined by blocking of
NT-3-mediated Schwann cell survival (used at 2.5 mg/ml). DB1 anti-
IFN-g antibodies were used as in previous experiments (1:50) in which
they were used for neutralizing engodenous IFN-g in Schwann cell
cocultures with lymphocytes (Kingston et al., 1989). For all antibodies,
unspeciﬁc effects on Schwann cell survival were excluded by applying the
antibodies to deﬁned medium only and neuregulin-treated cultures: none
of the antibodies reduced the survival of Schwann cells under these
conditions. The speciﬁcities of all antibodies have been published previ-
ously (manufacturer’s data and references).
Antibodies for immunohistochemistry were as follows. IGF-2 antibod-
ies were from Autogen Bioclear/Cymbus Bioscience. This antibody
shows ,0.01% cross-reactivity with IGF-2 or insulin, respectively, ac-
cording to the manufacturer’s instructions. PDGF-b receptor and TrkC
antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA), and
IGF receptor type I (IGF-RI), PDGF-BB, and NT-3 (G1651) were the
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were ﬁxed in cold methanol; for IGF-2 immunolabeling cells were frozen
twice, but not ﬁxed, before the application of the primary antibody; for
other antigens cells were ﬁxed with 4% paraformaldehyde. In all cases,
cells were preincubated in PBS, 0.1% Triton X-100, and 10% FCS, and
the antibodies were diluted in the same solution. Omission of the ﬁrst
antibody served as a control. Photographs were taken using conventional
and confocal ﬂuorescence microscopes.
Mitogen-activated protein kinase inhibition assay. Three hours after
plating, Schwann cells were preincubated in 360 ml of deﬁned medium
containing the mitogen-activated protein kinase kinase 1/2 (MEK 1/2)
inhibitor PD98059 (New England Biolabs, Hitchin, UK) for 1 hr. Without
changing the medium, 40 mlo f1 0 3 concentrated solutions of the appro-
priate growth factors or conditioned medium was applied to the wells.
The stock dilution of PD98059 was prepared at a concentration of 2.5 mM
in DMSO, ﬁnal concentrations were 20, 35, and 50 mM.
DNA synthesis assay. This assay was performed, as described previously
(Stewart et al., 1991; Jessen et al., 1994; Dong et al., 1995). Swiss 3T3
cells (a gift from Dr. R. Treisman) were cultured in 0.5% fetal calf serum
on noncoated glass coverslips. After 10 d in vitro the cells were switched
to different experimental media. Twenty-four hours later, BrdU was
added to the culture medium, and another 20 hr later the cells were ﬁxed
and immunolabeled.
Terminal transferase assay for cell death detection. Cell death was also
assessed using a detection method based on the TUNEL assay described
by Gavrieli et al. (1992). After ﬁxation of cells in 4% paraformaldehyde,
cells were washed in Tris-buffered saline and immersed in terminal
desoxynucleotidyl transferase buffer. The tailing reaction was performed
in 25 mM Tris-HCl, pH 6.6, 200 mM potassium cacodylate, 1 mM cobalt
chloride, 0.25 mg/ml bovine serum albumin, 2.5 mM biotin-16-dUTPs, 10
mM dATP, and 0.125 U/ml terminal transferase in a humidiﬁed container
at 37°C and 5% CO2 for 1 hr and terminated by transferring to 23 SSC.
After blocking in 4% BSA and 5% nonfat dry milk in PBS, TUNEL-
positive cells were visualized with ﬂuoresceinated avidin.
RNA preparation. Ultraspec RNA total RNA isolation reagent was
used, according to the manufacturer’s instructions, to purify RNA. Total
RNA was extracted from sciatic nerve and brachial plexus freshly dis-
sected from E14, E16, E18, and newborn rats. In other experiments, total
RNA was made from immunopanned Schwann cells prepared from
newborn rats and plated in tissue culture plastic dishes as described
above. For transection of the sciatic nerve, 4-d-old rats were anesthetized
with halothane, and the right sciatic nerve was transected. The proximal
end of the axotomized nerve was reﬂected to prevent nerve regeneration.
T w oa n d4da fter axotomy both the distal end of the transected nerve
and contralateral intact nerve were dissected and immediately used for
total RNA preparation.
Semiquantitative RT-PCR. In most cases, 500 ng of total RNA was
reverse-transcribed into cDNA in a 50 ml reaction containing 50 mM
Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl2,1 0m M DTT, 0.5 mM dNTPs,
100 ng of random hexamers as primer, and 200 U of RNase H
2 reverse
transcriptase (Superscript II). For detection of IGF-1 and IGF-RI in the
neonatal sciatic nerve and cultured Schwann cells, the RNA amount for
the cDNA synthesis was 10 times higher in the case of IGF-1 detection
and 50 times higher for IGF-RI detection. The reaction was incubated for
90 min at 42°C, followed by 10 min at 70°C. RNA was removed by
incubating the reaction for 30 min at 37°C in the presence of RNase A (0.2
mg/ml). The relative amount of cDNA synthesized from each sample was
determined by RT-PCR ampliﬁcation using 18S rRNA-speciﬁc primers
(Owens and Boyd, 1991). The primer pairs were designed as follows
(product size in parentheses): NT-3, forward primer, 59-GGTTG-
CAGGGGGATTGAT-39; reverse primer, 59-TATTCGTATCCAGC-
GCCA-39 (116 bp); TrkC, forward primer, 59-GCCAAGGGGGAG-
CTAGGACT-39; reverse primer, 59-AGCTCCACACATCACTCTCT-39
(341 and 299 bp; Offenha ¨user et al., 1995); IGF-1, forward primer, 59-
GGACCAGAGACCCTTTGCGGGG-39; reverse primer, 59-GGCT-
GCTTTTGTAGGCTTCAGTGG-39 (210 bp; Bell et al., 1986); IGF-RI,
forward primer, 59-GCAAGTTCTTCGTTTCGTCATGG-39; reverse
primer, 59-TTGTTCTCCTCGCTGTAGTAGAGG-39 (200 bp); IGF-2,
forward primer, 59-GTTCTTCAAATTCGACACCTGGAG-39; reverse
primer, 59-TGATGGTTGCTGGACATCTCCG-39 (203 bp); IGF-RII,
forward primer, 59-TGTACACTCTTCTTCTCCTGGCA-39; reverse
primer, 59-AGAGATGTTGATGTAGAAGACAGG-39 (186 bp; Rap-
polee et al., 1992); PDGF-B, forward primer, 59-AGACGAAGAT-
GGGGCTGAGCTG-39; reverse primer, 59-CACTGCACATTGCGGT-
TATTGC-39 (263 bp); and PDGF-Rb, forward primer, 59-GTTCGT-
CCTCAACATTTCGAGC-39; reverse primer, 59-AAACCTCGCTG-
GTGGTCATAGG-39 (413 bp).
One microliter of cDNA, corresponding to 10 ng of equivalent total
RNA (100 and 500 ng for IGF-1 and IGF-RI detection in postnatal day
0 nerve and cultured Schwann cells, respectively; see above), was ampli-
ﬁed in 100 ml of PCR reactions containing 13 reaction buffer (10 mM
Tris-HCl, pH 9.0, 50 mM KCl, and 0.1% Triton X-100), 1.5 mM MgCl2,
0.2 mM dATP, dGTP, dTTP, dCTP, 50 pmol of each primer (listed
above; 25 pmol for the TrkC primer pair) and 1.5 U of Taq DNA
polymerase. MgCl2 concentration, annealing temperature, and cycle
number were optimized for each primer pair.
After an initial step at 94°C for 3 min, cycling conditions were 94°C for
30 sec, 60°C for 1 min (55°C for the NT-3 and TrkC primer pairs), and
72°C for 30 sec before a ﬁnal extension period of 5 min at 72°C. To check
that the product was accumulating in a linear manner, 1⁄10 of each
reaction was electrophoresed at three cycle intervals (at a stage at which
product accumulation could be visualized) ona2o r2.5% agarose gel
stained with ethidium bromide. Numbers of cycles (indicated in the
ﬁgure legends) used in the RT-PCR reactions illustrated in Figure 6 were
within the linear part of the ampliﬁcation proﬁle.
RESULTS
Schwann cell death can be blocked by autocrine
survival loops
If Schwann cells secrete factors that regulate their own survival,
survival should be low at low cell density in vitro. To test this, cells
were dissociated from nerves of newborn animals, puriﬁed by
immunopanning, and plated at densities ranging from 125 to
12,000 cells per coverslip in simple deﬁned medium. Two days
later the cells were ﬁxed and treated with Hoechst dye, and the
number of surviving cells was counted using phase contrast and
ﬂuorescence microscopy (Fig. 1A). Cell survival was density-
dependent: 89% survival was obtained with 12,000 cells, whereas
only 52% of the cells survived over the 2 d period when 125 cells
were plated on PORN-coated coverslips. These cells died during
the next few days in vitro, indicating that death in low-density
cultures was not restricted to a subpopulation of cells (Fig. 1B).
The death in sparse cultures was not blocked by cell–cell contact,
because the survival was the same when 2000 cells were initially
plated in 20 ml drops, in which case most cells were seen to
contact each other, or in 80 ml drops, in which most cells were
single (data not shown).
The DNA condensation seen by the Hoechst staining indicated
death by apoptosis, and this was further supported by the use of
the TUNEL technique (Fig. 1D–G).
If Schwann cells secrete soluble survival factors, Schwann cell
conditioned medium should rescue Schwann cells that would
otherwise die in sparse cultures. We tested this usinga2d
survival assay and found that simple deﬁned medium conditioned
f o r1db ydense cultures of immunopanned cells from nerves of
7-d-old rats blocked cell death in low-density cultures (Fig. 1C).
The conditioned medium acted in a dose-dependent manner, with
optimum survival seen at a 10-fold dilution (99 6 0.6% of the
cells were rescued). To test whether the Schwann cell-derived
survival-promoting activity stimulated DNA synthesis in
Schwann cells, in addition to blocking apoptosis, the BrdU assay
and immunohistochemistry were used to detect DNA synthesis
during the last 20 hr in high-density cultures containing 12,000
cells per coverslip maintained for 2 d. Although these conditions
supported 95–100% survival, DNA synthesis was essentially ab-
sent (,0.1%). In positive control experiments, exposure of sim-
ilar cultures to the established Schwann cell mitogen combination
of FGF-2, IGF-1, and the cAMP-elevating agent forskolin (Stew-
art et al., 1996) resulted in .80% of the Schwann cells having
BrdU-labeled nuclei (see below). Conditioned medium, applied
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proliferation (see below).
Taken together these experiments indicated (1) that Schwann
cells can use autocrine growth factor loops to prevent their own
apoptosis, and (2) that at concentrations sufﬁcient to block death,
the factor(s) involved do not stimulate Schwann cell DNA
synthesis.
Experiments with neutralizing antibodies indicate that
IGF, NT-3, and PDGF-BB are components of the
autocrine growth factor loop
As a ﬁrst step toward establishing the molecular identity of the
autocrine Schwann cell survival activity, we tested whether the
effects of Schwann cell conditioned medium could be mimicked
by known growth factors. Using sparse cultures (125 cells per
coverslip) and relatively high growth factor concentrations, we
examined the ability of a number of growth factors to promote the
survival of immunopanned Schwann cells over 4 d. In these and
all subsequent experiments unless otherwisestated, the cells were
plated on PORN-coated glass coverslips. The factors included
LIF, ciliary-derived neurotrophic factor, epidermal growth fac-
tor, endothelin-1 and -3, FGF-2, nerve growth factor, BDNF,
NT-4, glial-derived neurotrophic factor, IGF-1, IGF-2, NT-3,
PDGF-AA, and PDGF-BB. Only IGFs (30–100 ng/ml), NT-3 (30
ng/ml), and PDGF-BB (30 ng/ml) enhanced survival in these
experiments signiﬁcantly (20–30% compared with deﬁned me-
dium controls).
This, together with the fact that all three factors have been
implicated in aspects of Schwann cell development and differen-
tiation (Eccleston et al., 1993; Cheng et al., 1996; Stewart et al.,
1996; Verdi et al., 1996; Oudega et al., 1997) and can be expressed
by Schwann cells (see below; for review, see Scherer and Salzer,
1996), raised the possibility that IGFs, NT-3, and PDGF-BB were
produced and secreted by Schwann cells and collectively formed
the autocrine survival loop.
To examine this, we tested whether blocking antibodies against
IGF, NT-3, or PDGF-BB would interfere with the ability of
conditioned medium to prevent cell death in sparse cultures (125
cells per coverslip) over 2 d. We found that two different IGF
antibodies completely abolished the ability of Schwann cell con-
ditioned media to rescue Schwann cells (Fig. 2A). These antibod-
ies were the SM1.2 antibody (Van Wyk et al., 1985), which blocks
the biological activity of IGF-1 and -2, and another IGF antibody
(AF-292), which primarily neutralizes IGF-2. In control experi-
ments, we veriﬁed the ability of both of these antibodies to block
speciﬁcally the effects of recombinant IGFs on Schwann cells (see
Materials and Methods). An NT-3 antibody, mAb 12, which has
previously been used to block the effects of endogenous NT-3 in
many systems (Gaese et al., 1994; Brill et al., 1995), also strongly
reduced the potential of conditioned media to rescue Schwann
cells, and again, this effect was conﬁrmed using an alternative
neutralizing NT-3 antibody, G1651 (Fig. 2A). These antibodies
reduced the rescue potential of the conditioned medium by 50–
80%. Last, we found that a neutralizing PDGF-BB antibody
reduced the ability of Schwann cell conditioned media to rescue
Figure 1. Autocrine survival circuit in Schwann cells. A, The survival of neonatal Schwann cells is density-dependent. Note that survival increases with
higher cell number, indicating secretion of autocrine growth factors into the medium. PORN (heavy line) and laminin (dotted line) substrate, 2 d assay.
B, Survival of low-density cultures decreases with time. PORN substrate, 125 cells per coverslip. C, Cells destined to die in low-density cultures can be
rescued by Schwann cell conditioned medium. PORN substrate, 125 cells per coverslip, 2 d assay. DM, Simple deﬁned medium; CM, Schwann cell
conditioned medium; numbers indicate dilutions with simple deﬁned medium. D, Appearance of Schwann cells in low-density cultures maintained in
conditioned medium (1:10) for 2 d. Note elongated morphology. PORN substrate, phase contrast optics. E–G, Schwann cells in low-density cultures die
by apoptosis in the absence of growth factors. E, Appearance of Schwann cells in low-density cultures maintained in simple deﬁned medium for 2 d. Note
a high proportion of dead or dying cells and a living cell (arrow) with typically short processes. PORN substrate, phase contrast optics. F, Same ﬁeld;
Hoechst staining of Schwann cell nuclei shows DNA condensation in dead cells. G, Same ﬁeld; TUNEL labeling of dead Schwann cells indicates DNA
fragmentation. The living cell (arrow) is unlabeled. Scale bar (D–G), 20 mm. In this and all subsequent graphs, each point represents the average of at
least three independent experiments 6 SEM. For deﬁnition of percent survival and percent rescue see Materials and Methods.
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bodies speciﬁcally blocked the mitogenic effect of recombinant
PDGF-BB on cultured Schwann cells (see Materials and Meth-
ods). Survival levels were not further reduced by combined ap-
plication of anti-NT-3 and anti-PDGF antibodies (data not
shown). In control experiments, blocking antibody DG2 against
FGF-2, blocking antibody DB1 against IFN-g (Fig. 2A), and
antibodies to TGF-b and BDNF (data not shown) had no signif-
icant effects on survival. Furthermore, the IGF antibodies did not
reduce Schwann cell survival induced by NT-3 and PDGF-BB,
the NT-3 antibodies did not reduce survival induced by IGF and
PDGF-BB, and the PDGF-BB antibodies did not reduce survival
supported by IGF and NT-3 (for documentation of the survival-
promoting activity of these growth factor combinations, see
below). None of these antibodies reduced the ability of
b-neuregulin-1 to support Schwann cell survival (see below).
The idea that IGFs acting via IGF-RI were a component of the
autocrine survival mechanism was further indicated by the ob-
servation that insulin at concentrations high enough to bind to
IGF-RI could substitute for the activity neutralized by IGF anti-
bodies. In this series of experiments, using 125-cell cultures and a
2 d survival assay, we found that a control survival of 49% in
deﬁned medium only was raised to 97% in the presence of
conditioned medium, suppressed to 45% (i.e., control levels) by
adding IGF antibodies to the conditioned medium, but raised
again to 95% when insulin (5 mg/ml) was added to the mixture of
conditioned medium plus IGF antibodies. Neutralizing antibodies
to IGF-RI were tested in two experiments and found to reduce
the rescue potential of Schwann cell conditioned media by 50–
55%. Using different methods we have previously reported that
PDGF-BB can act as an autocrine mitogen in Schwann cells
(Eccleston et al., 1990, 1993).
Together, these experiments indicate that the survival-
promoting activity found in media conditioned by Schwann cells
can be accounted for by a combination of growth factors, includ-
ing IGFs, NT-3, and PDGF-BB. The reported afﬁnities of the two
IGF antibodies for IGF-1 and -2, respectively (see Materials and
Methods), suggest that IGF-2 is the major IGF component (also
see immunohistochemical experiments using IGF-2 antibodies
below).
A mixture of IGF, NT-3, and PDGF-BB mimics the
effects of Schwann cell conditioned medium
The experiments with blocking antibodies indicated that the
survival activity in Schwann cell conditioned media can largely be
accounted for by a combination of IGFs, NT-3, and PDGF-BB. It
can be assumed that the conditioned medium is a complex com-
bination of a number of factors in addition to these three. Nev-
ertheless, if IGF, NT-3, and PDGF-BB together constitute a
critical survival signal, it should be possible to come close to
mimicking the survival activity of the medium by using a mixture
of the three factors only. The antibody experiments gave rise to
certain speciﬁc predictions for such experiments: (1) a combina-
tion of IGF, NT-3, and PDGF-BB should completely rescue
Schwann cells in an assay similar to that used to test the condi-
tioned medium; (2) the concentrations of the factors should be
such that all three factors are required for full survival; and (3) at
these concentrations, the combination of IGF with either NT-3 or
PDGF-BB should clearly be more effective than the combination
of NT-3 with PDGF-BB.
By performing survival assays using recombinant growth fac-
tors at various concentrations, we identiﬁed combinations of IGF,
NT-3, and PDGF-BB that fulﬁlled these criteria. The lowest
concentrations that mimicked Schwann cell conditioned medium
were IGF-1 and IGF-2 at 1–2 ng/ml together with NT-3 and
PDGF-BB at 0.5–1 ng/ml. Routinely, we therefore adopted the
combination of IGF-2 (1.6 ng/ml, 0.2 nM), NT-3 (0.8 ng/ml, 0.055
nM), and PDGF-BB (0.8 ng/ml, 0.03 nM) as the most parsimoni-
ous way of mimicking the effects of Schwann cell-derived factors
on Schwann cell survival (Fig. 2B). Neither NT-3 nor PDGF-BB
had signiﬁcant effects on their own at these concentrations (see
below and Fig. 3), and survival activity only increased modestly
when they were applied together. The combinations of IGF-2 plus
NT-3 or IGF-2 plus PDGF-BB achieved 50–60% rescue. At these
concentrations, therefore, complete rescue of Schwann cells de-
pended on the presence of all three components.
To further analyze the survival effects of IGF-2, NT-3, and
PDGF-BB, dose–response curves were constructed usinga2d
survival assay and 125 cells per coverslip as described above. As
mentioned previously, NT-3 and PDGF-BB when applied alone
had only small, although signiﬁcant, effects on Schwann cell
Figure 2. Similarities between the au-
tocrine Schwann cell survival signal and
IGF-2, NT-3, and PDGF-BB. A Neutral-
izing antibodies to IGF, NT-3, and
PDGF-BB inhibit the survivalactivityin
Schwann cell conditioned medium. Both
IGF antibodies completely abolish the
ability of conditioned medium to rescue
Schwann cells, whereas lesser but sub-
stantial inhibition is seen with the
PDGF-BB and both NT-3 antibodies.
Blocking antibodies to FGF-2 and
IFN-g have no effect on survival. PORN
substrate, 2 d assay, CM alone, Schwann
cell conditioned medium diluted 1:10;
anti-NT-39, NT-3 antibody mAb 12; anti-
NT-30, NT-3 antibody G1651; anti-IGF9,
IGF antibody SM1.2 (recognizes both
IGF-1 and -2); anti-IGF0, IGF-2 anti-
body AF-292. B, The combination
IGF-2, NT-3, and PDGF-BB in a minimal mixture of 1.6, 0.8, and 0.8 ng/ml, respectively, mimics the survival promoting effect of Schwann cell
conditioned medium. Shading of columns relates to A. Note that the minimal mixture rescues all cells and that the order of potency of all four
combinations shown in B is the one predicted by the neutralizing experiments shown in A. PORN substrate, 125 cells per coverslip, 2 d assay.
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more effective. At the highest concentration tested it supported
the survival of ;75% of the cells present at the start of the
experiment. Because at this time point (2 d) ;45% of the cells
survived even without added factors, this means that IGF-2 could
rescue just more than half of the cells that would otherwise die.
We then examined the dose–response relationship for each of
these factors under conditions in which all three are present, as
predicted in the conditioned medium. To reveal clearly the
survival-promoting effect of each factor, it was titrated on the
background of a constant concentration of the other two, which
was four times lower than that in the minimal mixture of IGF-2
(1.6 ng/ml), NT-3, and PDGF-BB (0.8 ng/ml). The dose-
dependent effects of these factors are shown in Figure 3. Taken
together these experiments show that a combination of IGF-2,
NT-3, and PDGF-BB supports Schwann cell survival in a manner
predicted by the experiments with blocking antibodies. This
strongly supports the notion that these factors are key compo-
nents of an autocrine Schwann cell survival signal.
Conditioned medium and IGF-2, NT-3, and PDGF-BB
show a similar bioactivity proﬁle: comparison
with b-neuregulin-1
Apart from the present work, the only deﬁned factor shown to
support the survival of neonatal Schwann cells is b-neuregulin-1
(Syroid et al., 1996; Trachtenberg and Thompson, 1996). Because
low levels of neuregulin mRNA can also be detected in Schwann
cells (Raabe et al., 1996), we examined b-neuregulin-1 as a
candidate component of the autocrine survival loop. We con-
ﬁrmed that b-neuregulin-1 supported full survival of neonatal
Schwann cells in the survival assay used above, i.e., witha2d
assay 125 cells plated on PORN coated coverslips in simple
deﬁned medium. This shows that the b-neuregulin-1 survival
signal is independent of the additional presence of supplements
to the medium, serum, laminin, or autocrine factors (Fig. 4A).
However, 8–10 ng/ml b-neuregulin-1 was required for maximum
effect, which was a 5–10 times higher concentration than that
needed for maximal survival support of E14 Schwann cell pre-
cursors (see Fig. 9B; Dong et al., 1995). Soluble ErbB4 receptor
protein, which speciﬁcally binds to and neutralizes neuregulin,
had no effect on survival in conditioned medium or in IGF-2,
NT-3, and PDGF-BB, although this protein reduced cell numbers
in b-neuregulin-1 in a dose-dependent way (Fig. 4A). Conversely,
blocking antibodies against IGF, NT-3, and PDGF-BB, used at
the same concentrations as those applied to conditioned media
(Fig. 2A), had no signiﬁcant effect on neuregulin-mediated
Schwann cell survival in this assay (Fig. 4B).
Additional tests revealed further differences between
b-neuregulin-1 and Schwann cell conditioned medium. First, us-
ing supplemented deﬁned medium, we compared the effects of
conditioned medium, IGF-2, NT-3, and PDGF-BB, and
b-neuregulin-1 on DNA synthesis in Schwann cells immuno-
panned from neonatal nerves. Ina2dmitogen assay on 125- and
2000-cell cultures using the BrdU method, 1% of cells were
labeled in the presence of conditioned medium, 30% were labeled
in the presence of 8 ng/ml neuregulin-b1, and 2.5% were labeled
in the presence of the minimum mixture of IGF-2, NT-3, and
PDGF-BB. Survival registered as 100% in each of these experi-
ments. These differences are unlikely to be explained by the use
of inappropriate concentrations, because many cells showed
BrdU labeling in the presence of neuregulin-b1 even at concen-
trations lower than that required for full survival and, conversely,
in the presence of IGF, NT-3, and PDGF-BB, the proportion of
BrdU-labeled cells remained at 1% even if the concentration of
all three factors was increased threefold. Thus, in conditioned
medium and in IGF-2, NT-3, and PDGF-BB, cells survive with-
out proliferating, under the present experimental conditions,
whereas in b-neuregulin-1 promotion of survival and DNA syn-
thesis occur at similar concentrations. Second, we (on the basis of
simple deﬁned medium) examined the stimulation of DNA syn-
thesis in Swiss 3T3 ﬁbroblasts. Again, conditioned medium and
the minimum mixture of IGF-2, NT-3, and PDGF-BB acted in a
similar way, generating nuclear labeling in 81 and 53% of the
cells, respectively. In contrast, the proportion of cells labeled in
the presence of 8 ng/ml neuregulin-b1 remained at the same level
as the controls, 12%. In one experiment involving triplicate
coverslips we compared the effects on DNA synthesis of adding 4
Figure 3. Dose–response curves of NT-3, IGF-2, and PDGF-BB alone
and on the background of the other two factors. Note that each of these
factors unambiguously promotes Schwann cell survival in a dose-
dependent manner provided the other two factors are present. Note that
when applied singly at the concentration used in the minimal mixture
(IGF-2, 1.6 ng/ml; NT-3 and PDGF-BB, 0.8 ng/ml), the effect of each
factor is small, although the mixture supports full survival (see Results
and Fig. 2B, ﬁrst column from left) showing a synergistic action in
promoting survival. The IGF-2 curve was constructed in the presence of
PDGF-BB and NT-3 both at 0.2 ng/ml. The NT-3 curve was constructed
in the presence of PDGF-BB at 0.2 ng/ml and IGF-2 at 0.4 ng/ml. The
PDGF-BB curve was constructed in the presence of NT-3 at 0.2 ng/ml and
IGF-2 at 0.4 ng/ml. PORN substrate, 125 cells per coverslip, 2 d assay.
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minimal mixture of IGF-2, NT-3, and PDGF-BB on the other.
Forskolin was added to a combination of FGF-2 (10 ng/ml) and
IGF-1 (50 ng/ml) as a positive control, because these factors are
established Schwann cell mitogens in the presence of forskolin.
The experiment was done in simple deﬁned medium on the
PORN surface. In the case of both conditioned medium and
IGF-2, NT-3, and PDGF-BB, addition of forskolin increased the
percentage of BrdU-labeled nuclei by approximately threefold,
although the proportions of BrdU-labeled nuclei always remained
#5%. In contrast, FGF-2 and IGF-1 plus forskolin provided a
strong mitogenic stimulus resulting in $65% of nuclei being
labeled. These preliminary experiments suggest a further simi-
larity between conditioned medium and the mixture of IGF-2,
NT-3, and PDGF-BB, because neither of these are converted to
a strong mitogen with addition of forskolin. It should be noted
that there is strong evidence that Schwann cell conditioned me-
dium contains an activity that inhibits Schwann cell DNA synthe-
sis (Muir et al., 1990; Eccleston et al., 1991). This activity is, of
course, not present in the minimal mixture, and this difference
will complicate any further comparison of the mitogenic effects of
conditioned medium and IGF-2, NT-3, and PDGF-BB.
Additional parallels between the actions of conditioned me-
dium and IGF-2, NT-3, and PDGF-BB and differences between
these agents and b-neuregulin-1 were revealed by examining
intracellular signaling pathways and the survival response of E14
Schwann cell precursors (see below). Together, these compari-
sons, summarized in Table 1, underscore the similarities between
Schwann cell conditioned medium and IGF-2, NT-3, and
PDGF-BB and render it unlikely that b-neuregulin-1 is a major
component of the autocrine survival mechanism in neonatal
Schwann cells.
Conditioned medium and the mixture of IGF-2, NT-3,
and PDGF-BB transduce their survival signal via the
MAP kinase pathway
To elucidate the intracellular pathways used by conditioned me-
dium and IGF-2, NT-3, and PDGF-BB, we investigated one of the
main pathways involved in growth factor signaling from cell
surface tyrosine kinase receptor proteins to the nucleus, the
MAP kinase pathway. Schwann cells were plated at 125 cells per
coverslip on PORN substrate in simple deﬁned medium, prein-
cubated with MEK 1/2 inhibitor PD98059 for 1 hr, and subse-
quently cultured with the inhibitor in conditioned medium, the
mixture of IGF-2, NT-3, and PDGF-BB, or b-neuregulin-1 for 48
hr. The inhibitor PD98059 has previously been shown to block
MEK 1 (IC50, 5–10 mM) and MEK 2 (IC50,5 0mM) phosphory-
lation and therefore activation in vitro (Alessi et al., 1995; Dudley
et al., 1995; Pang et al., 1995). Both conditioned medium and
IGF-2, NT-3, and PDGF-BB showed a strong dose-dependent
response to the MEK 1/2 inhibition. In contrast, b-neuregulin-1-
mediated survival was not affected by disruption of the MAP
Figure 4. b-Neuregulins support Schwann cell survival but are unlikely to be a major component of the survival signal in conditioned media. A, A soluble
form of the b-neuregulin-1 receptor ErbB4 inhibits b-neuregulin-1-mediated survival but has no effect on survival mediated by the minimal mixture of
IGF-2, NT-3, and PDGF-BB or conditioned medium (dilution, 1:10). Note that for direct comparison, cell number at the end of the assay (2 d) in
b-neuregulin-1 alone is arbitrarily set at 100%. Cell number in the presence of b-neuregulin-1 plus added ErbB4 is normalized to this value to obtain
relative survival. NRG-b1, b-Neuregulin-1, 8 ng/ml. PORN substrate, 125 cells per coverslip, 2 d assay. B, b-Neuregulin-mediated survival is unaffected
by neutralizing antibodies to IGF, NT-3, or PDGF-BB. DM, Simple deﬁned medium; NRG-b1, b-neuregulin-1, 8 ng/ml. For anti-NT-39 and anti-NT-30
see legend to Figure 2A; anti-IGF, IGF antibody SM1.2. The antibodies were applied at the same concentrations as those used to inhibit activity in
conditioned media. PORN substrate, 125 cells per coverslip, 2 d assay.
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tions used (Fig. 5). In control experiments, using high-density
cultures plated on laminin substrate in supplemented deﬁned
medium, we showed that b-neuregulin-1-induced Schwann cell
proliferation was reduced by 50% in the presence of PD98059 (50
mM), in agreement with reports that b-neuregulin-1 can activate
MAP kinase kinase in Schwann cells (Kim et al., 1997; Fiddes et
al., 1998).
These experiments show that conditioned medium and IGF-2,
NT-3, and PDGF-BB rely on the MAP kinase pathway for
mediating survival. Although b-neuregulin-1 can activate MAP
kinase, this is not required for survival signaling under the
conditions used here.
The candidate autocrine ligands and the
corresponding receptors are expressed in Schwann
cells in vitro and in vivo
If IGF-2 (or IGF-1), NT-3, and PDGF-BB are autocrine survival
signals, they should be expressed in newborn nerves and in vitro in
Schwann cells used to produce conditioned medium. To test this,
we used semiquantitative RT-PCR to compare IGF-1, IGF-2,
NT-3, and PDGF-B mRNA and their respective receptor mRNA
expression in newborn nerves and in immunopanned newborn
Schwann cells. As illustrated in Figure 6A, the different factors
and their corresponding receptors were detectable in both new-
born sciatic nerves and immunopanned Schwann cells. The rela-
tive amount of mRNA for PDGF-BB, PDGF-b receptor, IGF-2,
and IGF-RII in both newborn nerves and immunopanned cells
was higher than those for NT-3, TrkC, IGF-1, and IGF-RI recep-
tor, because 10 times less cDNA was necessary to detect the
former. Furthermore, the levels of IGF-1 mRNA were lower in
cultured cells than in the nerve, because ﬁve times more cDNA
from cultured cells was required for the detection of a comparable
signal from the two tissues. This is consistent with IGF-2 being
more important than IGF-1 in the conditioned medium, as sug-
gested by the antibody blocking experiments.
IGF-2, NT-3, and PDGF-BB as well as TrkC and PDGF-b
receptors were also detected in Schwann cells by immunohisto-
chemistry (Fig. 7). In nerves from 9 d- and 4-week-old rats that
were teased before immunolabeling for optimum resolution, im-
munolabeling for all three ligands was seen in Schwann cells. In
myelinated ﬁbers, immunolabeling was absent from myelin and
axons; the labeling was strongest in the perinuclear areas but
frequently extended along the outer cytoplasmic collar. TrkC and
PDGF-b receptor immunoreactivity showed comparable local-
ization, whereas IGF-RI receptor antibodies bound more weakly
in these preparations. Similar TrkC immunolabeling in the outer
cytoplasmic collar of myelinating cells has recently been reported
using other TrkC antibodies (Ruggiero et al., 1998). When this
immunostaining experiment was repeated using the distal stump
of nerves from 4-week-old animals that had been transected 3 d
previously, IGF-2 immunolabeling was noticeably stronger (Fig.
7B). In the cultured cells, the IGF-RI antibodies again bound only
weakly, although essentially all cells showed detectable labeling.
Previously, however, IGF-RI has been clearly localized on all
Schwann cells in cultures from neonatal rat nerves using an
alternative antibody (Schumacher et al., 1993). IGF-RII receptors
are also expressed by essentially all Schwann cells in vitro (Stewart
et al., 1996). Although the IGF-2 antibodies strongly labeled the
Figure 5. Survival in conditioned medium or in IGF-2, NT-3, and
PDGF-BB depends on MAP kinase activation, but survival in
b-neuregulin-1 is MAP kinase-independent. The graph shows the effect
of blocking the MAP kinase pathway (using 20, 35, or 50 mM PD98059) on
survival under three different conditions: in the minimal mixture of
IGF-2, NT-3, and PDGF-BB, in conditioned medium at a dilution of 1:10
(Cond.medium), and in b-neuregulin-1 at 8 ng/ml (NRG-b1). Note that
PD98059 has no effect on cell numbers in b-neuregulin. The number is
higher at the end of the assay than the number of cells initially plated
because of the mitogenic effect of b-neuregulin-1. The experiment was
done in simple deﬁned medium using PORN substrate, 125 cells per
coverslip, anda2dassay.
Figure 6. Semiquantitative RT-PCR analysis of the putative autocrine
factors and their respective receptor mRNAs during development, in
culture, and after nerve transection. A, RT-PCR on neonatal sciatic nerve
(Ne) and Schwann cells cultured from neonatal nerves (Sch). Examination
of IGF-1 (43 cycles), IGF-2 (28 cycles), PDGF-B (33 cycles), and NT-3
(48 cycles) and their corresponding receptors IGF-RI (45 cycles), IGF-
RII (33 cycles), PDGF-Rb (33 cycles), and TrkC (36 cycles) reveals the
presence of all mRNAs in newborn nerve as well as Schwann cells in
culture. B, These mRNAs are expressed in E18 nerves (immature
Schwann cells) but also earlier in embryonic development at E14 (pre-
cursor stage) and E16 (a transition point between precursors and imma-
ture Schwann cells). The cycle numbers for each primer pair were 33
cycles for IGF-1, 27 cycles for IGF-2, 46 cycles for NT-3, and 33 cycles for
the TrkC receptor. For all other primer pairs the cycle numbers were
identical to those listed in A. C, After nerve transection, mRNAs for all
factors and their receptors are expressed at the levels that are broadly
comparable to the contralateral control side. CON, Normal nerves of 2-
and 4-d-old rats; CUT, the distal stump of 2- and 4-d-old rats 2 and 4 d
after transection performed at birth. Cycle numbers were 30 for IGF-1, 27
for IGF-2, 40 for NT-3, and 35 for TrkC. For PDGF-B and PDGF-Rb 34
cycles were done. Again, 45 cycles were run for IGF-RI, and 33 were run
for IGF-RII.
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cells, because they work on unﬁxed, frozen tissue only (manufac-
turer’s information; our unpublished observations). The NT-3,
PDGF-BB, TrkC, and PDGF-b receptor antibodies clearly la-
beled the cultured cells. All the cells bound PDGF-BB antibodies;
;10% of Schwann cells showed weak or no labeling with PDGF-b
receptor antibodies, whereas NT-3 and TrkC antibodies bound to
an intermediate number of cells.
NT-3, IGF-1, IGF-2, and PDGF-B mRNA and the
corresponding receptor mRNA are expressed in
Schwann cell precursors and embryonic
Schwann cells
Because Schwann cell precursors did not show autocrine rescue
and were unresponsive to the IGF-2, NT-3, and PDGF-BB com-
bination of growth factors, it was possible that the precursors
failed to express some or all of the relevant growth factor or
growth factor receptor genes.
To test this we investigated, using semiquantitative RT-PCR,
the regulation of IGF-1, IGF-2, NT-3, and PDGF-B mRNA
expression and their corresponding receptors in embryonic sciatic
nerve between E14 (precursor stage) and E18 (Schwann cell
stage). As expected, all the factors and their receptors were
expressed at E18 (Fig. 6B). However, all nine mRNAs could also
be detected in E14 nerves. It remains possible that mRNA ex-
pression is not accompanied by protein expression in every case.
Alternatively, intracellular transduction of potential survival sig-
nals may differ between precursors and Schwann cells.
NT-3, IGF-1, IGF-2, and PDGF-B mRNA continue to be
expressed after neonatal sciatic nerve transection
In vivo, most neonatal Schwann cells surviveafter axotomy. If the
autocrine survival loop including NT-3, IGF-1 and -2, and
PDGF-B is involved in this process, the mRNA encoding these
factors and their receptors should continue to be expressed,
perhaps at higher levels, after axotomy. To test this, we used a
semiquantitative RT-PCR analysis of the different factors and
their corresponding receptors 2 and4da fter sciatic nerve tran-
section in newborn rats. Comparison of mRNA levels in the distal
part of the transected nerve and in the contralateral nerve showed
that eight genes continued to be expressed4da fter surgery (Fig.
6C). Although the limitations of the RT-PCR method should be
kept in mind, there was an indication of upregulation of mRNAs
for all of those genes except TrkC and PDGF-b. Taken together
these results are consistent with the three identiﬁed constituents
of the survival mixture being involved in the establishment of an
autocrine loop in vivo.
Longer-term survival requires both laminin and
autocrine signals
Although the experiments described above have made a strong
case for the mixture of IGF-2, NT-3, and PDGF-BB as an
autocrine Schwann cell survival signal, most of the observations
have been made within the ﬁrst2di nculture. We now asked
whether the autocrine mechanisms outlined above could support
Schwann cell survival for a longer time. Surprisingly, we found
Figure 7. Immunohistochemical experiments on teased nerves and cultured Schwann cells. A–C, E, G, I, Teased nerves from 4-week-old rats labeled
by antibodies as indicated. The nerve shown in B is the distal stump of a nerve that was transected 3 d before immunolabeling. Note that labeling is more
intense and widespread in B than in A. In myelinated ﬁbers, immunolabeling is generally most intense in nuclear regions (examples indicated with double
arrowheads) but is also seen in the outer cytoplasmic collar; this can be seen most clearly in E, G, and I. Examples of unmyelinated ﬁbers are indicated
with single arrowheads. D, F, H, J, Cultured Schwann cells made from 7-d-old rats. In all cases speckled immunolabeling was seen in the cell body region
and in cellular processes. Scale bars (A, D), 20 mm.
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tioned media nor the minimal IGF-2, NT-3, and PDGF-BB
combination supported survival much beyond 2 d under the
conditions of our assay, although the growth factor combination
was more effective than the conditioned medium (data not
shown). In agreement with this, even in dense Schwann cell
cultures survival deteriorated after 2 d (data not shown). These
experiments highlighted yet again similarities of action between
the Schwann cell-derived factors and IGF, NT-3, and PDGF-BB.
More importantly, however, they indicated that the autocrine
survival loop alone may not be sufﬁcient to guarantee Schwann
cell survival and pointed to the presence of a second survival
signal in cut nerves. We tested whether this could be laminin, a
main component of the Schwann cell basal lamina and a molecule
implicated in regulation of Schwann cell development (Bunge,
1993; Martini, 1994). We plated cells on laminin substrate at 125
cells per coverslip using simple deﬁned medium in the absence
of growth factors and compared their survival with that seen
previously on PORN substrate (see Fig. 1B). This showed lami-
nin alone to be ineffective in maintaining Schwann cell survival
(Fig. 8A). Marked improvement in longer-term survival was seen
when the minimal mixture of IGF-2, NT-3, and PDGF-BB
was applied in the presence of laminin, although some deterio-
ration was seen between days 4 and 6. When we tested the effects
of combining the use of a laminin substrate with exposure to
Schwann cell conditioned media, we found that full survival was
maintained for at least 6 d in vitro, the longest period tested (Fig.
8B). Under these conditions the cells assumed a markedly elon-
gated morphology.
We therefore suggest that Schwann cell survival in cut nerves is
ensured by synergistic interactions between the basal lamina that
surrounds denervated Schwann cells in vivo and an autocrine
signal. Together, this constitutes a signal capable of suppressing
Schwann cell death for a considerable time, although Schwann
cell numbers in distal stumps gradually decline after transection,
and most cells are eventually lost (Weinberg and Spencer, 1978).
Autocrine survival support is absent in Schwann cell
precursors and develops as a component of the
Schwann cell phenotype
Previously we showed that Schwann cell precursors died during
20 hr after plating in the absence of neurons, whereas Schwann
cells from newborn animals survived when plated under similar
conditions (Jessen et al., 1994). Schwann cell survival in these
experiments can now be explained by a combination of relatively
high cell density and the use of laminin, whereas the precursor
death indicated that these cells were unable to support their own
survival. This raised the possibility that the precursor–Schwann
cell transition, which takes place in the sciatic nerve between
E14–E15 and E17–E18, included the development of autocrine
survival loops. To test this we used precursors from E14 nerves
and cells from E18 nerves, i.e., early embryonic Schwann cells, in
density–survival experiments under conditions identical to those
used for newborn cells (see Fig. 1A). It was found that E14
precursors died even at very high densities, whereas E18 Schwann
cells showed a relationship between density and survival that was
comparable to that found with newborn cells (Fig. 9A). Similar
results were obtained on laminin and PORN substrates. We also
tested whether precursor death could be prevented either by
Schwann cell conditioned medium or by the mixture of IGF-2,
NT-3, and PDGF-BB. b-Neuregulin, an established precursor
survival factor, was used as a positive control (Dong et al., 1995).
It was found that neither the conditioned medium nor the factor
combination supported precursor survival (Fig. 9B). Similar re-
sults were obtained when the concentration of all three factors in
the mixture was increased threefold (data not shown). Both
conditioned medium and IGF-2, NT-3, and PDGF-BB supported
full survival of E18 cells (data not shown).
Together these experiments showed that the establishment of
the autocrine mode of support coincides with the formation of
Schwann cells from precursors and that these two cell types differ
in the survival signals to which they respond.
Figure 8. In the presence of autocrine signals, laminin promotes long-
term survival. A, In sparse cultures, Schwann cells die on laminin sub-
strate. Laminin substrate, 125 cells per coverslip. B, Laminin promotes
longer-term survival in the minimal mixture of IGF-2, NT-3, and
PDGF-BB and supports full survival for at least6di nt h epresence of
conditioned medium (CM; dilution, 1:10). Laminin substrate, 125 cells per
coverslip.
Figure 9. The emergence of an autocrine survival circuit coincides with
the generation of Schwann cells from precursors. A, Essentially all E14
precursors die irrespective of plating density, whereas the survival of
immature Schwann cells from E18 nerves is density-dependent. Identical
results were obtained on laminin or PORN substrates in experiments with
precursors. E18 Schwann cells die more slowly on laminin than on PORN.
Therefore, at the2dt i m ep o i n t sshown here, more cells are still alive at
each density point on laminin compared with PORN substrates. One day
assay for E14 precursors, 2 d assay for E18 Schwann cells. B, E14 Schwann
cell precursors cannot be rescued by Schwann cell conditioned medium or
by IGF-2, NT-3, and PDGF-BB. b-Neuregulin, an established precursor
survival factor, is included as a positive control. DM, Simple deﬁned
medium; CM, Schwann cell conditioned medium at a dilution of 1:10.
IGF-2, NT-3, and PDGF-BB were at the minimal concentrations, and
b-neuregulin-1 was at 2 ng/ml. PORN substrate, 1 d assay. Identical
results were obtained when the experiments shown in B were performed
in supplemented deﬁned medium and when the experiments were per-
formed on laminin substrate (data not shown).
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In this work we show that Schwann cells acquire the ability to
survive without axons by establishing an autocrine survival loop.
This mechanism is absent from Schwann cell precursors. We also
identify IGFs (probably IGF-2), NT-3, and PDGF-BB as impor-
tant components of this autocrine survival signal. By ensuring
that Schwann cells survive even in the absence of axons, the
autocrine signal is likely to be of crucial importance for repair in
the peripheral nervous system, because signiﬁcant axon regrowth
depends on living Schwann cells in the denervated distal part of
damaged nerves (Fawcett and Keynes, 1990). The demonstration
that Schwann cells can secrete biologically relevant quantities of
IGFs, NT-3, and PDGF-BB also has considerable implications for
cellular communication in the developing nervous system, in view
of the well documented effects of these factors, in particular IGFs
and NT-3, on survival and differentiation of other cells, including
neurons (Sara and Hall, 1990; Davies, 1996; Lewin and Barde,
1996; Feldman et al., 1997).
The present results show that E14 precursors, unlike Schwann
cells, do not show density-dependent survival, nor can Schwann
cell conditioned media rescue them from death. The survival of
precursors therefore depends on extrinsic signals, which appear to
come from axons (Dong et al., 1995; Meyer and Birchmeier, 1995;
Ciutat et al., 1996; Riethmacher et al., 1997) (Fig. 10). The results
also demonstrate that the ability for autocrine rescue develops as
a part of the precursor–Schwann cell transition that takes place
between E14–E15 and E17–E18. Nevertheless, Schwann cells
probably continue to rely in part on axons for survival for a
period that may last for up to several days after birth. This is
indicated by two observations. Most importantly, transection of
the sciatic nerve at birth triggers some increase in Schwann cell
death in the distal stump, whereas this response is reduced in
5-d-old animals and absent in 20-d-old or older animals (Grins-
pan et al., 1996; Syroid et al., 1996). Additionally, we have noted
that conditioned medium from cultures made from 7-d-old nerves
is severalfold more effective in supporting Schwann cell survival
than is medium from cultures generated from newborn nerves,
which may indicate a progressive increase in the effectiveness of
the autocrine survival loops (data not shown). In the perinatal
period, therefore, Schwann cells rely on a dual support system
with survival signals coming both from axons and the cells them-
selves (Fig. 10).
The identiﬁcation of IGF-2, NT-3, and PDGF-BB as compo-
nents of the autocrine survival mixture relies on antibody neu-
tralizing experiments, detailed mimicking of the survival activity
in Schwann cell conditioned media by a combination of these
factors in the approximate concentrations of 1.5 ng/ml (IGF) and
0.75 ng/ml (NT-3 and PDGF-BB), a similarity between this
mixture and conditioned media with respect to regulation of
survival and proliferation in Schwann cells, Schwann cell precur-
sors, and ﬁbroblasts, and the use of intracellular signaling path-
ways. Furthermore, we ﬁnd that these factors and their receptors
are expressed in perinatal and older Schwann cells and that their
expression is maintained in transected newborn nerves as ex-
pected if they played a role in survival support in injured nerves.
There is previous evidence for the expression of all of these
factors and receptors in normal and transected peripheral nerves
(Hardy et al., 1992; Funakoshi et al., 1993; Glazner et al., 1994;
Offenha ¨user et al., 1995; Pu et al., 1995; Cheng et al., 1996;
Svenningsen and Kanje, 1996; Hammarberg et al., 1998). The
present demonstration of a PDGF-BB autocrine loop conﬁrms
our previous conclusion using other methods, in which PDGF-BB
was detected as an autocrine Schwann cell mitogen because of a
different growth factor environment (Eccleston et al., 1990, 1993).
The RT-PCR measurements show that all of the relevant genes
are already expressed, at least at the mRNA level, in E14 precur-
sors and therefore fail to provide a simple explanation for the
absence of autocrine survival support and lack of effect of the
IGF, NT-3, and PDGF-BB combination in these cells. We have
not ascertained that expression of these mRNAs in precursors is
in every case accompanied by protein expression. Another pos-
sible explanation would be the absence of effective signal trans-
duction via receptors present on precursors, as seen in the case of
PDGF receptors on newly formed oligodendrocytes (Hart et al.,
1989, 1992).
To provide an effective rescue mechanism for Schwann cells
after nerve injury, survival of these cells must be guaranteed for
a time, although Schwann cells in distal stumps of cut nerves
appear to have a limited lifespan (Weinberg and Spencer, 1978; Li
et al., 1998; Terenghi et al., 1998). Our studies show that the
autocrine signal, in synergy with extracellular matrix molecules
such as laminin, is able to maintain cell survival in the medium
term. A clue to the mechanism underlying this interaction might
come from the observation that laminin, via integrins, activates
the MAP kinase pathway (Wei et al., 1998), a pathway we ﬁnd to
be activated by IGF-2, NT-3, and PDGF-BB and conditioned
medium and essential for survival signaling by these factors. It has
been suggested that some of the effects of laminin on Schwann
cells are mediated by activation of focal adhesion kinase
(Fernandez-Valle et al., 1998).
Although, using a number of different criteria, the minimal
mixture of IGF-2, NT-3, and PDGF-BB accounts very well for the
activity in the Schwann cell conditioned medium, it should be
borne in mind, ﬁrst, that the conditions in our experiments are
extremely simpliﬁed and, second, that the medium will contain a
number of potential signaling molecules apart from the three we
have identiﬁed. This includes, for instance, an activity that sup-
presses Schwann cell DNA synthesis (Muir et al., 1990; Eccleston
et al., 1991). It is not unlikely that in vivo and/or under different
culture conditions, other factors may play a part in autocrine
Figure 10. From paracrine signals to autocrine loops: the proposed
changes in survival regulation during Schwann cell development. The
survival of E14 Schwann cell precursors is regulated in a paracrine
manner by axon-derived b-neuregulin-1. During development, Schwann
cells establish autocrine circuits, which, in neonatal nerves, act in parallel
with the axonal signal. During Schwann cell maturation the autocrine
signal becomes sufﬁcient to prevent Schwann cell death in the absence of
axons. The factors IGF, NT-3, and PDGF-BB have been shown to be
major components of this autocrine signal in Schwann cells from 7-d-old
nerves. In vivo experiments indicate that at this date loss of axonal contact
after nerve transection no longer triggers signiﬁcant Schwann cell death
(Z. Dong, R. Mirsky, and K. R. Jessen, unpublished observations). A,
Axons; P, Schwann cell precursors; S, Schwann cells.
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involvement of additional factors is provided by the observation
that longer-term (6 d) survival is more effectively promoted by
laminin plus conditioned medium than by laminin plus the min-
imal mixture. This may suggest that, in addition to IGF-2, NT-3,
and PDGF-BB, the conditioned medium contains other factors
that are relevant for long-term Schwann cell survival. One of
these could be LIF, because this factor is upregulated in dener-
vated Schwann cells (Curtis et al., 1994; Kurek et al., 1996), and
there is evidence that LIF is present in Schwann cell conditioned
media (G. Tofaris, K. R. Jessen, and R. Mirsky, unpublished
data). It should also be pointed out that most of the present
experiments were performed on cells from young animals. It is
possible that in older nerves individual components of the mix-
ture we have identiﬁed might change or alter in relative
importance.
b-Neuregulins are expressed by Schwann cells in culture, and
there is evidence that they form a subliminal autocrine loop that
can be revealed in the presence of applied mitogens and is
involved in regulating proliferation (Raabe et al., 1996; Carroll et
al., 1997; Rosenbaum et al., 1997). Although b-neuregulin-1 may
well have some involvement in autocrine survival signaling, the
data are not consistent with b-neuregulins forming a major com-
ponent of the autocrine signal studied in the present work.
The present observations reveal a degree of similarity in how
the survival of oligodendrocytes and Schwann cells is regulated,
because IGFs, NT-3, and another form of PDGF, PDGF-AA,
have all been implicated in the control of oligodendrocyte sur-
vival and development (Barres et al., 1992, 1993a,b). The means
by which these factors are made available appear, however, to
have developed along two different lines. In the oligodendrocyte
lineage, they are thought to act in a paracrine manner, i.e., as
signals from other cells, such as astrocytes or neurons, whereas
the present work indicates that in the Schwann cells, their func-
tion is autocrine. From an evolutionary standpoint, this difference
may relate to the greater risk of trauma to peripheral nerves
compared with the CNS. It is likely that cells that rely on them-
selves for survival are less vulnerable to death during tissue
damage than cells that rely on their neighbors.
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